Position statements

PCDQ's opinion on biosimilar insulins

Here is an opinion from the Professional Council of Diabetes Québec (PCDQ) on the efficacy of biosimilar insulins for the treatment of diabetes.

Position statement on the shortage of GLP-1 receptor agonists and related drugs (Ozempic®, Trulicity®, Victoza®, Mounjaro®)

Position statement on the introduction of a tax on sugary drinks dedicated to prevention in 2022

Diabetes Québec believes that preventive measures must be put in place to reduce the pressure on the health care system and promote the health and well-being of the population in Québec.

Position statement on vaccination of people living with diabetes – Addendum

Diabetes Québec and its Professional Council have once again taken a position on COVID-19 vaccination for people with diabetes. Here are the details.

Position on tax credits for people living with insulin-dependent diabetes

Given the debate surrounding the tax credits for the benefit of people with insulin-dependent diabetes, Diabetes Québec and its Professional Council have expressed their opinion on the subject.

Position statement of the Diabetes Québec Professional Council – Adults living with diabetes must be given priority for COVID-19 vaccination

In light of the most recent scientific data1-2-3-4, the Diabetes Québec Professional Council (CPDQ) is reiterating its demand that the Québec government and the Québec health authority (INSPQ) revise its list of priority groups for COVID-19 vaccination so that all adults living with diabetes, including younger age groups with type 1 diabetes, can benefit from a vaccination much earlier than what has been proposed to date.